Skip to content
Dx

HCPCS Level II · Medical services and quality measures

M1194Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About M1194

M1194 is an HCPCS Level II code in the M series (medical services and quality measures), describing documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing).

It was added to HCPCS effective 01/01/2023.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Med rsn no imp/con mmr/msi
Date added
01/01/2023
Action effective
01/01/2023
BETOS
Z2

Related M11xx codes

Common questions about M1194

Is HCPCS M1194 still valid?

Yes. M1194 is active in the CMS October 2026 HCPCS file.

Does Medicare cover M1194?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.